CVRX | CVRx, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	12.31 - 12.73
52 Week Range	6.40 - 19.24
Beta	1.18
Implied Volatility	87.73%
IV Rank	14.03%
Day's Volume	107,960
Average Volume	235,948
Shares Outstanding	26,036,000
Market Cap	325,189,640
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2021-06-30

Valuation
Profitability
Growth
Health
P/E Ratio	-4.71
Forward P/E Ratio	-4.84
EPS	-2.65
1YR Price Target	12.00
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	200
Country	USA
Website	CVRX

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases.

CVRX's peers: AEMD, ANIK, AORT, AXDX, BFLY, BWAY, XTNT, CERS, SMLR, CODX, CTSO, OSA, LIVN, ELMD, KIDS, SRDX, LUNG, HSKA, OFIX, NPCE, SGHT, AXGN, DCTH, FNA, ICAD, INGN, LUCD, MXCT, NMTC, NSYS, NVRO, OM, PAVM, PROF, QIPT, QTRX, RBOT, RCEL, RXST, SRTS, SSKN, TCMD, TELA, TMDX, VERO, VMD, VREX, XAIR, ZBH, ZIMV, AIMD, CATX

*Chart delayed

Analyzing fundamentals for CVRX we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see CVRX Fundamentals page.

Watching at CVRX technicals we can see that long-term trend is bullish, while middle-term trend is bearish, but short-term trend is bullish. More technicals details can be found on CVRX Technicals page.